Cytta Corp.
Other OTCTotal Valuation
Cytta Corp. carries a market capitalization of 6.68M, placing it among publicly traded companies globally. Its enterprise value stands at 10.17M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.68M |
| Enterprise Value | 10.17M |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | 3,053.72 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | -6.99 |
| P/OCF Ratio | -6.99 |
Enterprise Valuation
| EV / Sales | 3,053.72 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Cytta Corp. maintains a current ratio of 2.37, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 526.04, indicating elevated leverage, while an interest coverage ratio of -9.11 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.37 |
| Quick Ratio | 1.73 |
| Debt / Equity | 526.04 |
| Debt / EBITDA | N/A |
| Interest Coverage | -9.11 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -429.18 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Cytta Corp.'s stock has declined approximately -13.125% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | -13.125% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Cytta Corp. generated 3,330.00 in revenue and converted that into -2.94M in net income, yielding earnings per share of -0.01. EBITDA reached -2.62M, while operating income came in at -2.65M.
| Revenue | 3,330.00 |
| Gross Profit | -17,210.00 |
| Operating Income | -2.65M |
| Pretax Income | -2.94M |
| Net Income | -2.94M |
| EBITDA | -2.62M |
| EBIT | -2.65M |
| Earnings Per Share (EPS) | -0.01 |
Cash Flow
Cytta Corp. produced -1.45M in operating cash flow over the past twelve months.
| Operating Cash Flow | -1.45M |
| Capital Expenditures | N/A |
| Free Cash Flow | -1.45M |
| FCF Per Share | 0.00 |
Margins
Cytta Corp. operates with a gross margin of -454.32, reflecting its pricing power and cost economics. The operating margin of -79,543.75 and net profit margin of -88,314.17 provide insight into operational efficiency.
| Gross Margin | -454.32 |
| Operating Margin | -79,543.75 |
| Pretax Margin | -88,314.17 |
| Profit Margin | -88,314.17 |
| EBITDA Margin | -78,624.62 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -20.02 |
| FCF Yield | -14.31 |
Stock Splits
Cytta Corp.'s most recent stock split took place on April 29, 2013 with a 300:1 split ratio.
| Last Split Date | 4/29/2013 |
| Split Ratio | 300:1 |
Scores
Cytta Corp. posts an Altman Z-Score of -86.19, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -86.19 |